Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-19.96	548.36	685.07
Graham Fair Price	8.38	31.52	29.08
PEG	-93.91	4.69	-77.00
Price/Book	-9.87	56.69	62.89
Price/Cash Flow	-56.32	986.00	2257.14
Prices/Earnings	-18.57	175.39	215.38
Price/Sales	-0.18	206.11	206.49
Price/FCF	-56.32	986.00	2257.14
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.97	0.58	0.56
Operating Margin	15.19	0.32	0.27
ROA	12.99	0.06	0.05
ROE	0.07	0.08	10.68
ROIC	0.06	0.07	3.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.08	-81.08
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.11	0.07	-32.09
EPS QOQ	-0.03	0.37	1237.41
FCF QOQ	-0.65	1.13	74.02
Revenue QOQ	0.13	-0.07	-46.68
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	50.01	49.79	-0.46
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.09	0.09	-4.33
Quick Ratio	1.94	1.98	2.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.69	23.38	3.02
Cash	8.88	8.63	-2.85
Capex	-0.88	-0.96	-8.67
Free Cash Flow	0.63	1.34	112.56
Revenue	6.91	6.43	-6.98
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.10	2.15	2.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.17	0.12	-31.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating